(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REMODULIN (TREPROSTINIL) INJECTION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

REMODULIN (TREPROSTINIL) INJECTION

ST13

US500000077352192

Class

5

Filing

77352192

Registration

3883260

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

02/28/2021

Trademark type

Combined

Nice classes

5

Filing date

12/14/2007

Registration date

11/30/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/28/2021

Last transaction

02/28/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2010-03-00

First use in commerce

2010-03-00

Drawing code

3

Owner type

03

Owner location

Silver Spring, MD

Examiner

BESCH, JAY

Law office

L80

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the word "REMODULIN" with two swooshes over the top and the words "(treprostinil) injection" underneath.

Holders and representatives

Holders

U. C. (pessoa física)

Representatives

Norm J. Rich Foley & Lardner LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cardiovascular pharmaceuticals

Publications

History of USPTO decisions and trademark events.

57 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/28/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/28/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/28/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/28/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

11/17/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/30/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/19/2016

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/19/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/19/2016

E815

TEAS SECTION 8 & 15 RECEIVED

10/11/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

11/30/2010

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/26/2010

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

10/23/2010

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/22/2010

DMCC

DATA MODIFICATION COMPLETED

10/20/2010

XAEC

EXAMINER'S AMENDMENT ENTERED

09/27/2010

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/27/2010

GNEA

EXAMINERS AMENDMENT E-MAILED

09/27/2010

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

09/27/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/21/2010

GNRT

NON-FINAL ACTION E-MAILED

09/21/2010

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/21/2010

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/01/2010

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/31/2010

EX4G

SOU EXTENSION 4 GRANTED

08/31/2010

IUAF

USE AMENDMENT FILED

08/17/2010

EXT4

SOU EXTENSION 4 FILED

08/17/2010

EEXT

SOU TEAS EXTENSION RECEIVED

08/17/2010

EISU

TEAS STATEMENT OF USE RECEIVED

08/17/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/17/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/17/2010

EX3G

SOU EXTENSION 3 GRANTED

02/15/2010

EXT3

SOU EXTENSION 3 FILED

02/12/2010

EEXT

SOU TEAS EXTENSION RECEIVED

02/12/2010

EX2G

SOU EXTENSION 2 GRANTED

08/13/2009

EXT2

SOU EXTENSION 2 FILED

08/05/2009

EEXT

SOU TEAS EXTENSION RECEIVED

08/05/2009

EX1G

SOU EXTENSION 1 GRANTED

02/23/2009

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/23/2009

EXT1

SOU EXTENSION 1 FILED

02/09/2009

EEXT

SOU TEAS EXTENSION RECEIVED

02/09/2009

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

08/19/2008

PUBO

PUBLISHED FOR OPPOSITION

05/27/2008

NPUB

NOTICE OF PUBLICATION

05/07/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/21/2008

ALIE

ASSIGNED TO LIE

04/21/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/16/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/01/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/01/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/01/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/26/2008

GNRT

NON-FINAL ACTION E-MAILED

03/26/2008

CNRT

NON-FINAL ACTION WRITTEN

03/26/2008

RFTP

REMOVED FROM TEAS PLUS

03/26/2008

DOCK

ASSIGNED TO EXAMINER

03/22/2008

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

12/20/2007

NWAP

NEW APPLICATION ENTERED

12/19/2007

Continuous trademark protection

Get notified about every new filing that threatens REMODULIN (TREPROSTINIL) INJECTION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.